<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(7.5 0 0 7.5 37.7953 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.152" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">500</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 37.7953 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.677 0.847 1.161 1.499 1.985 2.323 2.682 3.204 3.705 4.225 4.922 5.444 5.966 6.488 6.989" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">Ultrarresúmenes </svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 118.523 787.491) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.235" x="0 1.062 2.149" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)">DAE</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 151.402 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.35 0.865 1.351 1.689 2.175 2.525 2.695 3.181 3.531 4.046 4.405 4.927 5.442 5.928 6.266 6.752 7.186 7.368 7.885 8.407 8.757 9.262 9.784 10.134 10.651 11.166 11.683 12.184 12.366 12.8 12.982 13.499 14.021 14.543" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)"> para la preparación de oposiciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 756.8018) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 1.101 1.374 1.591 2.308 2.803 3.076 3.571 4.066 4.561 4.778 4.995 5.268 5.763" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antimetabolitos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 121.014 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 745.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.723 2.167 2.556 3 3.444 3.666 4.055 4.722 5.166 5.388 5.832 6.276 6.498 6.942 7.331 7.72 7.942 8.386 8.83 9.052 9.441 9.885 10.552 10.996 11.218 11.662 11.884 12.328 12.55 12.939 13.161 13.605 13.827 14.216 14.494 14.716 15.16 15.438 15.882 16.104 16.548 16.992 17.27 17.714 17.936 18.325 18.769 19.213 19.657 19.879 20.157 20.601 20.879 21.546 21.99 22.379 22.823" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Mecanismo de acción complejo y distinto para cada fármaco.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 734.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.723 2.167 2.445 2.889 3.167 3.445 3.889 4.278 4.722 5 5.444 5.666 5.921 6.365 6.809 7.087 7.531 7.975 8.419 8.863 9.085 9.474 9.752 10.196 10.451 10.895 11.339 11.594 12.038 12.427 12.649 13.093 13.537 13.792 14.07 14.514 14.736 14.958 15.347 15.791 16.046 16.49 16.934 17.378 17.633 18.077 18.466 18.744 19.188 19.632 19.887 20.109 20.553 20.997 21.219 21.663 21.885 22.329 22.773 23.217 23.661 23.916 24.36 24.804 25.248 25.503 25.947 26.391 26.724 26.946 27.613 28.057 28.279 28.534 28.756 29.423 29.867 30.089 30.533 30.755 31.199 31.643 32.087 32.531 32.786 33.008 33.452 33.707 33.985 34.429 34.873 35.317 35.706 36.095 36.317 36.761 37.205 37.46 37.904 38.348 38.603 39.047 39.436 39.658 40.102 40.546 40.801 41.245 41.467 41.911 42.133 42.577 42.855 43.299 43.577 44.021 44.243 44.465 44.854 45.298 45.553 45.997 46.252 46.641" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Metotrexato: antagonista de ácido fólico que actúa inhibiendo una enzima, impidiendo la reducción de ácido dihidrofólico a su</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 488.943009 734.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.255 0.533 0.977 1.255 1.922 2.366" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> forma </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701005 723.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.111 1.333 1.722 2.166 2.388 2.61 3.054 3.498 3.942 4.164 4.386 4.83 5.274 5.496 5.94 6.384 6.606 6.828 7.272 7.494 7.883 8.105 8.549 8.827 9.271 9.66 9.882 10.271 10.493 10.882 11.326 11.548 11.992 12.214 12.658 12.936 13.158 13.602 14.046 14.268 14.824 15.38 15.991 16.213 16.435 16.991 17.491 18.102 18.324 18.713 18.935 19.379 19.657 20.101 20.379 20.823 21.045 21.489 21.933 22.322" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">activa, que inhibe la síntesis celular de ADN, ARN y proteínas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196905 712.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.1669 1.6109 2.0549 2.2769 2.6659 3.1099 3.4989 3.7209 4.1649 4.6089 5.0529 5.4419 5.6639 5.8818 6.1038 6.5478 6.9918 7.3808 7.8248 8.4918 8.7138 9.1578 9.3757 9.5977 9.9867 10.2087 10.4867 10.9307 11.2087 11.6527 12.0967 12.3187 12.7627 13.2067 13.4287 13.6466 13.8686 14.0865 14.5305 14.9745 15.4185 15.6965 16.1405 16.5845 16.8065 17.2505 17.6945 17.9165 18.1344 18.4124 18.6344 19.0784 19.5224 19.9664 20.4104 20.8544 21.0764 21.5204 21.9644 22.1864 22.4043 23.0713 23.5153 23.7933 24.2373 24.5153 24.7933 25.2373 25.6263 26.0703 26.3483 26.7923 27.0143 27.2363 27.4542 27.8432 28.2872 28.7312 29.1202 29.5642 29.8422 30.0601 30.5041 30.9481 31.166 31.833 32.277 32.944 33.388 33.6059 33.8279 34.2719 34.5499 34.7719 34.9898 35.4338 35.8778 36.1558 36.5998 37.0438 37.3218 37.7658 38.1548 38.3768 38.5988 39.0428 39.2648 39.4827 39.7607 40.2047 40.6487 41.0927 41.3707 41.8147 42.0227 42.2447 42.4626 43.1296 43.5736 43.8516 44.2956 44.5736 44.8516 45.2956" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: leucemia (citarabina, ﬂ udarabina, tioguanina, metotrexato), cáncer de mama (5-ﬂ uorouracilo, tegafur, metotrex</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 476.341215 712.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.388 1.6052 1.9942 2.2114 2.6004 3.0444 3.4884" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">ato) y cán-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701009 701.838799) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.111 1.333 1.777 2.221 2.61 2.888 3.166 3.388 3.777 4.221 4.443 4.665 5.109 5.387 5.609 5.831 6.275 6.719 6.997 7.441 7.885 8.163 8.607 8.996 9.218 9.44 9.884 10.106 10.328 10.606 11.05 11.494 11.938 12.216 12.66 12.938 13.16" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">cer gástrico (5-ﬂ uorouracilo, tegafur).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.19691 690.838998) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9446 1.3886 1.6666 2.1106 2.4996 2.7776 3.2216 3.6106 3.8172 4.2612 4.7052 5.0942 5.5382 5.8162 6.2052 6.6492 7.0382 7.2602 7.4668 7.9108 8.1328 8.4108 8.8548 9.1328 9.5768 9.9658 10.1878 10.6318 11.0758 11.5198 11.9088 12.1154 12.5594 13.0034 13.3924 13.6704 13.9484 14.3924 14.6144 15.0584 15.3364 15.7804 16.1694 16.4474 16.6694 17.1134 17.5574 17.7794 18.2234 18.6124 18.8344 19.041 19.485 19.929 20.207 20.485 20.929 21.207 21.651 22.04 22.262 22.651 22.873 23.317 23.761 24.205 24.4116 24.8006 25.0072 25.2852 25.7292 26.1182 26.3402 26.7292 26.9512 27.3952 27.8392 28.2832 28.4898 28.9338 29.3778 29.5998 30.2668 30.7108 31.1548 31.5988 31.8068 32.0288 32.2354 32.7354 33.1794 33.6234 33.83 34.497 34.941 35.385 35.829 36.218 36.4246 37.0916 37.3136 37.7576 37.9796 38.4236 38.8676 39.3116 39.7556 40.0336 40.4776 40.8666 41.3106 41.5886 42.0326 42.4216 42.6282 43.0722 43.5162 43.9602 44.1668 44.6108 44.8328 45.0394 45.4834 45.7614 46.2054" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: alteraciones gastrointestinales, nefrotoxicidad y toxicidad pulmonar. Son menos mielodepresores que el grup</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 485.035216 690.838998) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.6506 1.0946 1.5386 1.7452 1.9672 2.4112 2.8002" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">o de los </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701014 679.839198) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.11 1.554 1.776 1.998 2.442 2.886 3.164 3.608 3.997" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">alquilantes.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 657.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 657.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.3389 0.9449 1.4399 1.7129 1.9299 2.4249 2.6419 3.1369 3.4099 3.6269 4.1219 4.6169 5.0559 5.2728 5.7678 5.9848 6.2578 6.7528 7.1918 7.4648 7.9598 8.2328 8.4498 8.9448 9.4398" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Antibióticos citostáticos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 151.056004 657.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196905 646.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.108 6.552 6.996 7.385 7.829 8.496 8.718 9.162 9.551 9.773 10.162 10.384 10.606 10.828 11.272 11.55 11.994 12.661 13.105 13.494" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: leucemias y linfomas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196905 635.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.3889 1.6669 2.1109 2.4999 2.7779 3.2219 3.6109 3.9508 4.3948 4.8388 5.2278 5.6718 5.9498 6.3388 6.7828 7.1718 7.3938 7.7337 8.1227 8.5667 8.8447 9.2887 9.5107 9.9547 10.2327 10.6767 11.0657 11.2877 11.6767 11.8987 12.3427 12.7867 13.2307 13.4527 13.7926 14.2366 14.4586 14.7366 15.1806 15.4586 15.9026 16.2916 16.5136 16.9576 17.4016 17.8456 18.2346 18.5745 19.0185 19.4625 19.8515 20.1295 20.4075 20.8515 21.0735 21.5175 21.7955 22.2395 22.6285 22.9065 23.1285 23.5725 24.0165 24.2385 24.6825 25.0715 25.2935 25.6334 26.0774 26.5214 26.9654 27.2434 27.6874 28.0764 28.2984 28.7424 29.1864 29.5263 29.9703 30.4143 30.7542 30.9762 31.4202 31.7601 32.4271 32.8711 33.3151 33.7591 33.9811 34.4251 34.765 35.209 35.598 36.042 36.486 36.708 37.0479 37.4919 37.7139 38.1579 38.6019 39.0459 39.4349 39.6569 40.1009 40.3229 40.6628 41.1068 41.3288 41.6068 42.0508 42.3288 42.7728 43.1618 43.3838 43.8278 44.2718 44.7158 45.1048 45.4447 45.8337 46.2777 46.5557 46.9997" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: cardiotoxicidad, alteraciones gastrointestinales, depresión de la médula ósea, alopecia, alteraciones cután</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 492.18302 635.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.6169 2.0059" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">eas y </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.70101 624.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.61 2.054 2.276 2.72 3.164 3.386 3.775 4.219 4.608 4.83 5.274 5.496 5.94 6.162 6.606 7.05 7.328 7.772 8.05 8.272 8.661 9.105 9.772 9.994 10.438" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">neurológicas e hiperuricemia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.19691 613.838799) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.944 3.388 3.777 3.999 4.443 4.887 5.109 5.498 5.72 5.942 6.386 6.83 7.497 7.719 8.163 8.385 8.774 9.052 9.33 9.774 10.163 10.385 10.829 11.273 11.495 11.717 12.18 12.402 12.624 13.013 13.457 13.679 14.068 14.512 15.179 15.623 16.067 16.345 16.623 17.067 17.511 17.733 18.122 18.566 19.233 19.677 19.899 20.343 20.787 21.231 21.675 21.953 22.397 22.786 23.008 23.397 23.841 24.23 24.452 24.841 25.285 25.729 26.007 26.451 26.84 27.062 27.451 27.673 27.895 28.284 28.728 28.95 29.394 29.783 30.061 30.339 30.783 31.172 31.616 32.005 32.449 32.893" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Precaución si administración IV: se comportan como agentes vesicantes si se extravasan.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 591.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 0.823 1.318 1.813 2.03 2.525 2.742 3.237 3.732 4.171 4.388 4.883 5.378 5.595 5.812 6.307 6.802 7.297 7.792" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Alcaloides del podoﬁ</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 137.551501 591.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.2475 0.4645" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> lo</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 146.187001 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196897 580.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9448 1.1668 1.6108 2.0548 2.2768 2.6658 3.1098 3.4988 3.7208 4.1648 4.6088 5.0528 5.4418 5.6638 5.8846 6.3286 6.6066 7.0506 7.4946 7.9386 8.3276 8.5496 8.9936 9.4376 9.6584 9.8804 10.1024 10.3244 10.7684 11.0464 11.4904 12.1574 12.6014 12.9904 13.2124 13.4332 13.8222 14.2662 14.7102 15.0992 15.5432 15.8212 16.042 16.486 16.93 17.1508 17.5948 17.9838 18.4278 18.7058 18.9278 19.3718 19.5938 19.8146 20.2036 20.6476 21.0916 21.4806 21.9246 22.2026 22.4234 22.8674 23.3114 23.5322 23.9762 24.4202 24.6422 25.3092 25.7532 26.1972 26.418 26.807 27.0278 27.4718 27.9158 28.1366 28.4146 28.8586 29.2476 29.5256 29.7476 30.1366 30.5806 30.8026 31.2466 31.4686 31.6894 32.0784 32.2992 32.5772 33.0212 33.4652 33.6872 34.1312 34.5752 34.9642 35.1862 35.6302 36.0742 36.295 36.517 36.739 37.183 37.627 38.016 38.46 39.127 39.349 39.793 40.182 40.404 40.6248 40.8468 41.0688 41.5128 41.7908 42.2348 42.9018 43.3458 43.7348 43.9568 44.1776 44.5666 45.0106 45.2326" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: etopósido (linfomas, cáncer de ovario, cáncer de pulmón y de testículo) y tenipósido (leucemias, linfomas, veji</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 474.274782 580.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.3308 1.7748 2.2188 2.4408 3.1078 3.5518 3.9958" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">ga, pulmón </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.700968 569.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.611 0.889 1.333 2 2.444 2.722 3.166 3.555 3.777 3.999 4.443 4.721 4.999 5.443 5.832 6.11 6.554 6.998 7.442 7.886 8.108 8.552 8.941 9.163 9.83 10.274 10.496 10.718 11.162 11.606 12.05 12.439 12.661" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">y tumores intracraneales malignos).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196868 558.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.611 3.833 4.277 4.721 5.11 5.554 5.832 6.221 6.665 7.054 7.276 7.498 8.165 8.387 8.831 9.053 9.497 9.941 10.385 10.829 11.107 11.551 11.94 12.162 12.606 13.05 13.272 13.494 13.938 14.16 14.438 14.882 15.16 15.604 15.993 16.215 16.659 17.103 17.547 17.936 18.158 18.602 19.046 19.435 19.713 19.991 20.435 20.657 21.101 21.379 21.823 22.212 22.49 22.712 23.156 23.6 23.822 24.266 24.655 24.877 25.266 25.488 25.932 26.154 26.598 27.042 27.486 27.875 28.097 28.541" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: mielodepresión, alteraciones gastrointestinales y alopecia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 536.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 1.101 1.429 1.646 2.085 2.58 3.075 3.57 4.009 4.226 4.721 5.216 5.433 5.65 6.145 6.362 6.857 7.352 8.069 8.564 8.837 9.332 9.605 10.1 10.595 10.812 11.307" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Derivados de la camptotecina</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 171.413999 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 525.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.164 6.608 7.052 7.496 7.774 8.218 8.607 9.051 9.495 9.717 9.939 10.328 10.772 11.216 11.605 12.049 12.327 12.549 12.993 13.437 13.659 14.103 14.492 14.936 15.214 15.436 15.88 16.102 16.324 16.713 16.935 17.157 17.435 17.657 18.101 18.545 18.823 19.267 19.656 20.1 20.544 20.766 20.988 21.377 21.821 22.265 22.654 23.098 23.376 23.598 23.987 24.431 24.653 25.097 25.375 25.653 26.097 26.486 26.764 27.208 27.43 27.652 27.874" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: topotecan (cáncer de ovario) y irinotecan (cáncer colorrectal). </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 514.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.611 3.833 4.277 4.721 5.11 5.554 5.832 6.221 6.665 7.054 7.276 7.498 7.942 8.164 8.608 9.052 9.496 9.885 10.107 10.551 10.773 10.995 11.439 11.661 12.105 12.383 12.661 13.105 13.549 13.771 13.993 14.437 14.881 15.325 15.714 16.158 16.602 16.991 17.213 17.435 17.824 18.268 18.935 19.157 19.435 19.879 20.268 20.49 20.712 21.156 21.545 21.823 22.267 22.711 22.933 23.377 23.599 23.821 24.265 24.709 25.153 25.82 26.042 26.486 26.708 27.097 27.319 27.763 28.207 28.651 28.929 29.207 29.651 30.095 30.539 30.983 31.205 31.649" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: alopecia, diarrea, náuseas, vómitos, astenia, anemia y neutropenia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 492.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1.333 1.666 1.944 2.555 3.111 3.722 4.333 4.611 5.167 5.667 5.945 6.445 7.056 7.556 7.834 8.445 9.056 9.612 9.89 10.446 10.946 11.279 11.89 12.446 13.057 13.335 13.835 14.446 15.057 15.446 16.002 16.28 16.558 17.114 17.392 18.336 18.614 18.947 19.558 20.058 20.336 20.836 21.114 21.614 22.17 22.448 23.059 23.337 23.893" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Antineoplásicos que actúan sobre la mitosis celular</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 470.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 470.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.284 1.562 2.006 2.45 2.894 3.116 3.338 3.782 4.06 4.504 4.782 5.004 5.226 5.504 5.726 6.17 6.614 7.058 7.502 7.724 8.168 8.612 8.834 9.278 9.5 9.722 10.166 10.444 10.888 11.277 11.721 12.11 12.554 12.776 13.22 13.664 13.886 14.108 14.552 14.774 15.441 15.663 15.941 16.385 16.774 16.996 17.385 17.607 18.051 18.273 18.495 19.162 19.606 19.828 20.272 20.716 21.16 21.382 21.604 22.048 22.27 22.548 22.992 23.436 23.714 24.158 24.602 25.046 25.435 25.824 26.046 26.49 26.934 27.156 27.545 27.989 28.211 28.655 28.877 29.321 29.529" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Actúan interﬁ riendo en el proceso de la mitosis e impiden la reproducción celular.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 459.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 459.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 459.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 0.823 1.318 1.813 2.03 2.525 2.742 3.237 3.732 4.171 4.388 4.883 5.378 5.595 5.812 6.307 6.524 6.963 7.18 7.675 8.17" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Alcaloides de la vinca</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 143.180097 459.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 448.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.427 1.649 2.093 2.537 2.759 3.203 3.592 3.87 4.092 4.536 4.98 5.202 5.424 5.813 6.035 6.479 6.923 7.367 7.756 7.978 8.422 8.866 9.088 9.31 9.699 9.921 10.365 10.754 11.032 11.254 11.643 11.921 12.143 12.587 13.031 13.253 13.475 13.864 14.086 14.53 14.974 15.252 15.696 15.918 16.362 16.584 17.028 17.472" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Vinblastina, vindesina, vincristina, vinorelbina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 437.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.108 6.33 6.774 7.052 7.496 8.163 8.607 8.996 9.218 9.44 9.662 10.106 10.55 10.939 11.383 12.05 12.272 12.716 12.938 13.16 13.549 13.993 14.437 14.826 15.27 15.548 15.77 16.214 16.658 16.88 17.547 17.991 18.658 19.102 19.324 19.713 19.935 20.324 20.768 21.212 21.601 22.045 22.323 22.545 22.989 23.433 23.655 24.099 24.543 24.765 25.432 25.876 26.32" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: linfomas, leucemia, cáncer de mama y cáncer de pulmón.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 426.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.611 3.833 4.277 4.721 5.11 5.554 5.832 6.221 6.665 7.054 7.276 7.498 8.165 8.387 8.831 9.053 9.497 9.941 10.385 10.829 11.107 11.551 11.94 12.162 12.606 13.05 13.272 13.494 13.938 14.382 14.826 15.104 15.548 15.826 16.27 16.659 16.881 17.27 17.492 17.936 18.38 18.824 19.046 19.268 19.712 19.934 20.378 20.822 21.266 21.655 21.877 22.321 22.543 22.932 23.154 23.598 23.82 24.098 24.542 24.82 25.264 25.653 25.875 26.319 26.763 27.207 27.596 27.818 28.262 28.706 29.095 29.373 29.651 30.095 30.317 30.761 31.039 31.483 31.872 32.15 32.372 32.816 33.26 33.482 33.926 34.315" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: mielodepresión, neurotoxicidad, alopecia y alteraciones gastrointestinales.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 415.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.944 3.388 3.777 3.999 4.443 4.887 5.109 5.553 5.997 6.219 6.608 7.052 7.274 7.718 8.162 8.829 9.051 9.495 9.717 10.106 10.384 10.662 11.106 11.495 11.717 12.161 12.605 12.827 13.049 13.512 13.734 13.956 14.345 14.789 15.011 15.4 15.844 16.511 16.955 17.399 17.677 17.955 18.399 18.843 19.065 19.454 19.898 20.565 21.009 21.231 21.62 22.064 22.453 22.675 23.064 23.508 23.952 24.23 24.674 25.063 25.285 25.674 25.896 26.118 26.507 26.951 27.173 27.617 28.006 28.284 28.562 29.006 29.395 29.839 30.228 30.672 31.116" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Precaución en su administración IV: se comportan como vesicantes si se extravasan.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 393.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 393.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 393.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.415 0.91 1.349 1.844 2.061 2.556 3.051" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Taxoides</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 96.607799 393.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 382.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.33 6.774 7.163 7.607 7.885 8.329 8.718 9.162 9.384 9.606 9.828 10.217 10.661 11.105 11.494 11.938 12.216 12.438 12.882 13.326 13.548 14.215 14.659 15.326 15.77 15.992 16.214 16.603 16.825 17.269 17.713 18.102 18.324 18.546 18.824 19.268 19.657 20.101 20.323 20.545 20.767 21.156 21.6 22.044 22.433 22.877 23.155 23.377 23.821 24.265 24.487 24.931 25.32 25.764 26.042 26.264 26.708 26.93 27.152 27.596 28.04 28.262 28.929 29.373 29.817 30.039 30.428 30.65 31.317 31.761 32.428 32.872 33.094" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: docetaxel (cáncer de mama) y paclitaxel (cáncer de ovario, pulmón y mama).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 371.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.611 3.833 4.277 4.721 5.11 5.554 5.832 6.221 6.665 7.054 7.276 7.498 7.942 8.164 8.442 8.886 9.164 9.608 9.997 10.219 10.663 11.107 11.551 11.94 12.162 12.606 13.05 13.439 13.717 13.995 14.439 14.661 15.105 15.383 15.827 16.216 16.494 16.716 17.16 17.604 17.826 18.27 18.659 18.881 19.103 19.492 19.936 20.38 20.824 21.268 21.49 21.934 22.378 22.822 23.211 23.433 23.655 24.099 24.543 24.987 25.431 25.709 26.153 26.597 26.819 27.041 27.263 27.707 27.985 28.429 28.818 29.04 29.429 29.651 30.095 30.539 30.983 31.261 31.705 31.927 32.371 32.815 33.037 33.426 33.87 34.259" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: alteraciones gastrointestinales, sanguíneas, hepatobiliares y neurológicas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 349.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1.333 1.666 1.944 2.555 3.111 3.722 4.333 4.611 5.167 5.667 5.945 6.445 7.056 7.556 7.834 8.445 9.056 9.445 10.389 11 11.611 12.167 12.445 13.001" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Antineoplásicos hormonales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 327.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 327.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.284 1.562 2.006 2.45 2.894 3.116 3.56 4.004 4.226 4.504 4.948 5.615 6.059 6.337 6.781 7.17 7.392 7.781 8.225 8.614 9.058 9.28 9.669 9.947 10.391 10.78 11.002 11.669 11.891 12.335 12.779 13.057 13.501 13.723 14.167 14.611 15.055 15.499 15.943 16.387 16.831 17.053 17.497 17.941 18.163 18.385 18.829 19.218 19.496 19.718 20.385 20.829 21.051 21.495 21.717 22.161 22.605 22.883 23.55 23.994 24.438 24.882 25.104" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Actúan en tumores cuyo crecimiento depende del estímulo hormonal:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 316.8021) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 1.101 1.374 1.869 2.364 2.859 3.354 3.571 4.01 4.283 4.778 5.217 5.434 5.929 6.424 6.641 7.136 7.575 7.848 8.176 8.671 9.166 9.661 10.156 10.651" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antagonistas de estrógenos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 165.006 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 305.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9446 1.4446 1.6666 2.1106 2.5546 2.9986 3.4426 3.8866 4.3306 4.5552 4.8332 5.2772 5.6662 6.1102 6.5542 6.8322 7.2762 7.5542 7.9982 8.3872 8.6118 9.0558 9.4448 9.7228 10.0008 10.4448 10.8888 11.3328 11.7768 11.9988 12.3878 12.8318 13.2208 13.4454 13.6674 13.9454 14.3894 15.0564 15.5004 15.8894 16.1114 16.3894 16.8334 17.2774 17.7214 17.9434 18.168 18.446 18.89 19.168 19.612 20.279 20.501 20.779 21.223 21.667 22.111 22.333 22.5576 22.8356 23.2796 23.5016 23.8906 24.3346 24.7236 25.0016 25.4456 25.8896 26.1676 26.3896 26.6142 27.0582 27.2828 27.5048 27.9488 28.3928 28.6148 29.0588 29.5028 29.9468 30.1714 30.3934 30.8374 31.062 31.34 31.784 32.062 32.729 33.173 33.562 33.784 34.228 34.672 34.8966 35.3406 35.7846 36.0092 36.4532 36.8422 37.1202 37.3982 37.8422 38.2862 38.7302 39.1742 39.6182 40.0072 40.2318 40.6758 41.1198 41.5638 42.0078 42.4518 42.8958 43.3398 43.7838 44.1728 44.3974 44.6194 45.0634 45.7304 45.9524 46.3964 46.8404 47.2844" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Bloquean receptores estrogénicos (tamoxifeno, toremifeno, fulvestant) o inhiben la formación de estrógenos endógenos (aminogl</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 492.741017 305.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.444 1.666" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">uteti-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701005 294.838499) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 0.889 1.333 1.777 1.999 2.221 2.665 3.109 3.553 3.942 4.22 4.498 4.942 5.275 5.719 5.941 6.163 6.385 6.829 7.218 7.662 8.329 8.773 9.162 9.44 9.884 10.328 10.772 10.994 11.216 11.438 11.882 12.16 12.438 12.882 13.215 13.659 13.881 14.103 14.325" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">mida, anastrozol, exemestano, letrozol). </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196905 283.838699) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.275 6.719 7.163 7.552 7.996 8.274 8.496 8.94 9.384 9.606 10.273 10.717 11.384 11.828" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: cáncer de mama.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196905 272.838899) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.288 0.9453 1.3993 1.6873 2.1413 2.5403 2.8283 3.2823 3.6813 3.9866 4.4406 4.8946 5.2936 5.7476 6.0356 6.4346 6.8886 7.2876 7.5196 7.8249 8.2789 8.5109 8.7989 9.2529 9.5409 9.9949 10.3939 10.6259 11.0799 11.5339 11.9879 12.3869 12.6922 13.1462 13.6002 13.8882 14.5652 15.0192 15.3072 15.7612 15.9932 16.4472 16.9012 17.1332 17.5322 17.9862 18.3852 18.6172 18.9225 19.3765 19.8305 20.2295 20.5175 20.8055 21.2595 21.4915 21.9455 22.2335 22.6875 23.0865 23.3745 23.6065 24.0605 24.5145 24.7465 25.2005 25.5995 25.9048 26.3038 26.6091 27.0631 27.5171 27.9711 28.2591 28.7131 28.9451 29.3991 29.8531 30.0851 30.4841 30.9381 31.3371 31.5691 31.8744 32.4404 32.8944 33.3484 34.0254 34.4794 34.8784 35.1104 35.4157 35.8147 36.2687 36.5567 37.0107 37.4097 37.8637 38.2627 38.4947 38.8 39.254 39.708 40.385 40.839 41.127 41.415 41.869 42.323 42.555 43.009 43.3143 43.7133 44.1673 44.6213 44.8533 45.3073 45.7613 45.9933 46.2986 46.6976 47.0029 47.4569 47.7449 48.1989 48.4869" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: alteraciones dermatológicas, gastrointestinales y neurológicas. Además, sofocos, hemorragia vaginal y pruri</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 503.648111 272.838899) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.288 0.732" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">to </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701009 261.839099) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.399 0.853 1.085 1.484 1.938 2.156" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">vulvar.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 239.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 239.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 239.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 1.101 1.374 1.869 2.364 2.859 3.354 3.571 4.01 4.283 4.778 5.217 5.434 5.929 6.424 6.641 7.136 7.631 8.126 8.454 8.949 9.444 9.939 10.434 10.929" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antagonistas de andrógenos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 167.507999 239.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 228.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.275 6.719 7.163 7.552 7.996 8.274 8.496 8.94 9.384 9.606 10.05 10.328 10.772 11.161 11.439 11.883 12.161 12.605" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: cáncer de próstata.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 217.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.611 3.833 4.277 4.721 5.11 5.554 5.832 6.221 6.665 7.054 7.276 7.498 7.942 8.164 8.442 8.886 9.164 9.608 9.997 10.219 10.663 11.107 11.551 11.94 12.162 12.606 13.05 13.439 13.717 13.995 14.439 14.661 15.105 15.383 15.827 16.216 16.494 16.716 17.16 17.604 17.826 18.27 18.659 18.881 19.103 19.547 19.991 20.435 20.879 21.157 21.601 21.879 22.323 22.712 22.934 23.323 23.545 23.989 24.433 24.877 25.099 25.488 25.71 25.932 26.376 26.765 26.987 27.431 27.875 28.153 28.375 28.764 29.208 29.652 30.096 30.485 30.707 31.151 31.595 31.817 32.206 32.65 32.872 33.316 33.705 34.094 34.316 34.76 35.204 35.426 35.87 36.314 36.592 36.814 37.258 37.702 38.146 38.424 38.868 39.312 39.756 40.2 40.422 40.811 41.255" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: alteraciones gastrointestinales, hepatotoxicidad y los derivados de su acción antiandrogénica.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 195.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.551 0.879 1.374 1.869 2.364 2.803 3.076 3.571 4.066 4.561 5.056 5.551" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Progestágenos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 119.106898 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 184.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.111 2.555 2.833 3.277 3.666 3.944 4.388 4.61 4.888 5.332 5.61 6.054 6.498 6.942 7.386 7.664 7.886 8.275 8.719 8.941 9.385 9.829 10.107 10.329 10.718 11.162 11.384 11.828 12.272 12.494 12.716 13.16 13.382 13.826 14.215 14.604 14.826 15.27 15.714 15.936 16.38 16.824 17.102 17.324 17.768 18.157 18.435 18.713 19.157 19.601 20.045 20.489 20.711 21.1 21.544 21.766 22.21 22.654 22.876 23.098 23.542 23.764 24.431 24.875 25.097 25.541 25.819 26.041 26.43 26.652 27.096 27.54 27.762 28.206 28.428 28.65 29.094 29.538 30.205 30.649 30.927 31.371 31.593 32.037 32.481 32.703 32.925 33.369 33.591 34.035 34.424 34.813 35.035 35.479 35.923 36.145 36.589 37.033 37.311 37.533 37.977 38.421 38.865 39.143 39.587 40.031 40.475 40.919 41.141 41.53 41.974" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Su efecto terapéutico deriva de la acción antiestrogénica en la mujer y en el hombre de la acción antiandrogénica.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 173.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.275 6.719 7.163 7.552 7.996 8.274 8.496 8.94 9.384 9.606 10.05 10.328 10.772 11.161 11.439 11.883 12.161 12.605 12.827 13.049 13.716 14.16 14.827 15.271 15.493 15.937 16.159 16.603 17.047 17.491 17.935 18.602 19.046 19.324 19.602 19.824 20.268" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: cáncer de próstata, mama o endometrio.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 151.8021) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.606 1.101 1.596 1.813 2.308 2.803 3.298 3.737 3.954 4.449 4.944 5.161 5.6 6.206 6.534 7.085" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Análogos de LH-RH</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 134.414999 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 140.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.666 3.11 3.499 3.721 4.165 4.609 5.053 5.442 5.664 5.886 6.275 6.719 7.163 7.552 7.996 8.274 8.496 8.94 9.384 9.606 10.05 10.328 10.772 11.161 11.439 11.883 12.161 12.605 12.827 13.216 13.438 13.827 14.271 14.715 15.104 15.548 15.826 16.048 16.492 16.936 17.158 17.825 18.269 18.936 19.38 19.602 19.824 20.268 20.712 21.156 21.6 22.267 22.711 22.989 23.267 23.489 23.933 24.322 24.544 24.933 25.155 25.544 25.766 25.988 26.21 26.654 26.932 27.376 28.043 28.487 28.709 29.153 29.431 29.875 30.153 30.375 30.819 31.263 31.485" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Indicaciones: cáncer de próstata y cáncer de mama, endometriosis y ﬁ broma uterino. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 129.8385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9451 1.3891 1.6671 2.1111 2.5001 2.7781 3.2221 3.6111 3.8282 4.2722 4.7162 5.1052 5.5492 5.8272 6.2162 6.6602 7.0492 7.2712 7.4883 7.7103 8.1543 8.3763 8.7653 8.9873 9.4313 9.6533 10.3203 10.7643 11.2083 11.4863 11.9303 12.1474 12.5914 13.0354 13.4794 13.9234 14.3674 14.8114 15.0285 15.4725 16.1395 16.5835 17.0275 17.4715 17.7495 18.1935 18.4715 18.6886 18.9106 19.3546 19.5717 19.9607 20.1827 20.6267 20.9047 21.3487 22.0157 22.4597 22.7377 23.1817 23.4037 23.8477 24.2917 24.5137 24.9577 25.1748 25.6188 26.0628 26.2799 26.5019 26.9459 27.163 27.607 28.051 28.329 28.773 29.051 29.718 30.162 30.606 31.05 31.494 31.716 31.9331 32.3771 32.8211 33.0382 33.2602 33.7042 33.9213 34.5883 35.0323 35.2543 35.6983 35.9763 36.1983 36.4154 36.8044 37.2484 37.5264 37.9704 38.3594 38.8034 39.1924 39.4144 39.6315 40.0205 40.4645 40.9085 41.3525 41.6305 42.0745 42.4635 42.6855 42.9026 43.2916 43.7356 44.0136 44.4576 44.6796 45.1236 45.5676 45.7896 46.0067 46.4507" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efectos adversos: inicialmente pueden empeorar la sintomatología de la enfermedad. En la mujer: sofocos, sudores, cefalea, al</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 485.244015 129.8385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1 1.444 1.833 2.055 2.499" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">teracio-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701005 118.838699) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.943 2.387 2.609 2.831 3.275 3.719 4.386 4.83 5.108 5.33 5.719 5.941 6.33 6.774 7.218 7.662 8.106 8.55 8.994 9.438 9.66 10.049 10.493 10.937 11.159 11.603 12.047 12.269 12.491 12.713 13.157 13.601 13.823 14.267 14.489 14.711 15.155 15.599 16.266 16.71 16.988 17.432 17.654 17.876 18.098 18.765 19.209 19.653 19.931 20.375 20.819 21.208 21.43 21.874 22.096 22.485 22.929 23.318 23.762 24.206 24.428 24.65 25.039 25.261 25.705 26.149 26.427 26.871 27.093 27.537 27.981 28.203 28.647 29.091 29.313 29.535 29.979 30.201 30.423 30.645 31.089 31.311 31.755 32.199" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">nes del humor y sequedad vaginal. En el hombre: impotencia sexual y pérdida de la libido.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 96.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1.333 1.666 1.944 2.555 3.111 3.722 4.333 4.611 5.167 5.667 5.945 6.445 7.056 7.556 7.834 8.445 9.056 9.612 9.89 10.446 10.946 11.279 11.89 12.446 13.057 13.335 13.835 14.446 15.057 15.446 16.002 16.28 16.836 17.114 17.392 17.892 18.17 18.67 19.003 19.559 20.503 21.059 21.337 21.615 22.226 23.17 23.781 24.392 24.67 25.003 25.559 25.948 26.226 26.837" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Antineoplásicos que actúan sobre el sistema inmunitario </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.444 1.722 2.166 2.444 3.111 3.555 3.944 4.388 4.777 4.999 5.443 5.887 6.109 6.553 6.942 7.22 7.664 7.886 8.33 8.608 9.052 9.496 9.94 10.162 10.606 11.05 11.328 11.772 12.216 12.605 12.827 13.271 13.715 13.937 14.159 14.603 14.825 15.269 15.658 16.047 16.269 16.713 17.157 17.379 17.823 18.267 18.489 18.711 19.1 19.322 19.711 19.989 20.433 21.1 21.544 21.766 21.988 22.432 23.099 23.543 23.987 24.209 24.487 24.931 25.209 25.431 25.875 26.097 26.319 26.763 26.985 27.429 27.873 28.262 28.484 28.928 29.372 29.761 29.983 30.427 30.871 31.093 31.482 31.704 32.093 32.537 32.926 33.37 33.814 34.258 34.48 34.98 35.48 36.036 36.258" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Los fármacos de este grupo potencian la acción del sistema inmunitario: aldesleukina y vacuna BCG. </svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>